OncoHost
A technology company transforming the approach to precision medicine for improved patient outcomes.
53 employees · est. 2017 · Binyamina, Israel
Solid IO
ENDING THE GUESSWORK IN CANCER CARE | Patient-specific organ-on-chip technology for precision oncology & immunotherapy
8 employees · est. 2025 · Helsinki, Finland
OncoHost is the older company (2017 vs 2025); OncoHost is the larger of the two.
Side-by-Side Comparison
| Metric | OncoHost | Solid IO |
|---|---|---|
| Founded | ||
| Founded | 2017 older | 2025 |
| Headquarters | ||
| Headquarters | Binyamina, Israel | Helsinki, Finland |
| Employees | ||
| Employees | 53 larger | 8 |
| Industry | ||
| Industry | Biopharma, Biotechnology, Health Care | Not tracked yet |
| Funding Stage | ||
| Funding Stage | Series C | Seed |
| Total Funding | ||
| Total Funding | $52.56M | $800.00K |
| Funding Rounds | ||
| Funding Rounds | 4 | 1 |
| Services | ||
| Services | Not tracked yet | Tumor-on-chip platform, Patient-specific treatment insights, Immunotherapy research support, Early-stage clinical trial facilitation |
| Target Customers | ||
| Target Customers | Not tracked yet | Pharmaceutical Companies, Biotech Firms, Cancer Clinics, Oncologists, Researchers |
| Taxonomy | ||
| Taxonomy | Precision Medicine, Technology Company, PROphet® Platform, Proteomic Pattern Analysis, Non-small Cell Lung Cancer (NSCLC), Immunotherapy Decision-making, Clinical Utility, Biomarker Development, Precision Diagnostics, Plasma-based Testing, Oncology, Patient Outcomes, Entrepreneurial Leadership, Industry Expertise, Clinical Trial | Organ-on-chip Technology, Precision Oncology, Immunotherapy, Tumor Microenvironment, Clinical Trials Optimization, Drug Development Acceleration, Biomarker Validation, Personalized Immunotherapies, Cancer Research, Patient-specific Treatment, Oncology Data Insights, Pharmaceutical Innovation, Biotech Collaboration, Precision Medicine |
| Website | ||
| Website | oncohost.com | solid-io.com |
About OncoHost
OncoHost is a technology company based in Israel that is revolutionizing the field of precision medicine to enhance patient outcomes. The company's flagship product, PROphet®, utilizes a plasma-based, proteomic pattern analysis to deliver personalized treatment insights for non-small cell lung cance...
About Solid IO
Solid IO, founded in 2025 and headquartered in Finland, is pioneering advancements in precision oncology and immunotherapy through its unique organ-on-chip technology. The company's slogan, "ENDING THE GUESSWORK IN CANCER CARE," underscores its commitment to providing patient-specific data that empo...
Be first to know when either one moves
Funding rounds, hiring surges, leadership changes and stack switches at OncoHost and Solid IO — tracked continuously, sent the day they land.
Funding, hiring, leadership and stack changes at OncoHost and Solid IO — by email.
Frequently Asked Questions
Compare OncoHost with someone else
Start typing a company name or domain.